Internationally Renowned Artificial Organs Expert Joins HepaLife(TM)
HepaLife(TM) Bioartificial Liver: Analysts Forecast Artificial Liver Market to Surpass $2.7 Billion by 2010
HepaLife Expands Scientific Team and Continues Development of First-of-its-Kind Artificial Liver Device
HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting
HepaLife Completes Private Placement for $2.5 Million
HepaLife Expands Management Team on Heels of Favorable Outcomes of First-of-Its-Kind Bioartificial Liver Device
HepaLife Achieves Major Milestone in Development of Artificial Liver Device
HepaLife's Cells for Artificial Liver Device Significantly Outperform Most-Widely Used Human Liver Cell Line
